Trial Profile
Glivec (imatinib mesylate)/Litalir (hydroxyurea) plus initial radiotherapy after surgery in patients with newly diagnosed glioblastoma multiforme followed by Glivec and Litalir - A phase I/II safety evaluation study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2011
Price :
$35
*
At a glance
- Drugs Hydroxycarbamide (Primary) ; Imatinib (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 31 May 2011 New trial record